This page shows the latest Brintellix news and features for those working in and with pharma, biotech and healthcare.
Epilepsy treatment Sabril ( vigabatrin) also had a good quarter with sales climbing 42 to 186m krone and Lundbeck also booked 59m krone from antidepressant Brintellix( vortioxetine) in the quarter, although it
Lundbeck launches Brintellix in first EU market. The antidepressant set to sell worldwide. ... Danish pharma company Lundbeck is selling its new antidepressant Brintellix in its home market, the first European launch for the product.
EMA backs Lundbeck's Brintellix in depression. Drug recommended for approval to treat major depressive episodes in adults. ... In the latest round of EU drug recommendations, Lundbeck won backing for the use of Brintellix in the treatment of adult
Lundbeck buoyed by Brintellix approval in US. FDA gives green light for to Cipralex/Lexapro successor in depression. ... Lundbeck was celebrating yesterday after the FDA approved its new antidepressant Brintellix, a successor to the big-selling
Lundbeck and Takeda submit depression drug for US approval. Brintellix could help Lundbeck overcome loss of patent protection for Lexapro/Cipralex. ... Lundbeck's plans to find a replacement for its big-selling antidepressant Lexapro/Cipralex continue
J&J spent $12m to advertise the drug, which was approved in the US in April 2013, was up 84 on the same period in 2013, while Lundbeck's antidepressant Brintellix was
More from news
Approximately 5 fully matching, plus 15 partially matching documents found.